However, to begin to explore the effect of SM on SUMOylation in the context of EBV infection, we examined the cellular SUMO1 profile in EBV-positive gastric carcinoma cells (AGS-EBV) after lytic reactivation with and without SM depletion with SM-targeted siRNA. The gene discussed is SUMO1; the disease is gastric carcinoma.